Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects - Boulton, David W.; Smith, Charles H.; Li, L.; Huang, Jian; Tang, Angela; LaCreta, Frank P. (Clinical drug investigation, 2011)
Keywords: Adamantane - administration & dosage; Adamantane - adverse effects; Adamantane - analogs & derivatives; Adamantane - pharmacokinetics; Administration, Oral; Adult; Analysis; Cross-Over Studies; Delayed-Action Preparations; Dipeptides - administration & dosage; Dipeptides - adverse effects; Dipeptides - pharmacokinetics; Dipeptidyl-Peptidase IV Inhibitors - administration & dosage; Dipeptidyl-Peptidase IV Inhibitors - adverse effects; Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics; Dosage and administration; Drug Combinations; Drug Therapy, Combination; Female; Food-Drug Interactions; Health aspects; Humans; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - adverse effects; Hypoglycemic Agents - pharmacokinetics; Internal Medicine; Male; Medicine; Medicine & Public Health; Metformin; Metformin - administration & dosage; Metformin - adverse effects; Metformin - pharmacokinetics; Original Research Article; Patient compliance; Pharmacology/Toxicology; Pharmacotherapy; Saxagliptin; Tablets; Therapeutic Equivalency; Young Adult; United States; Tablet Core; Metformin; Initial Combination Therapy; Healthy Adult Subject; Saxagliptin